ArticleAdvanced biomedical research2017

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma.

Shirin Kouhpayeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.